Cempra (CEMP) January volatility above 200 into FDA PDUFA Date

Cempra (NASDAQ: CEMP) January call option implied volatility is at 201, February is at 154; compared to its 52-week range of 69 to 260 into a FDA PDUFA Date for Cempra Oral Solithromycin IV formulation on December 28, 2016.

You May Also Be Interested In

• Burlington Stores (BURL) 3700 contracts of September 25 weekly 305 puts trade
• Collegium Pharma (COLL) 2700 contracts of August 39 calls trade
• Intuitive Machines (LUNR) call put ratio 2.7 calls to 1 put as share price down 3%